BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33492602)

  • 1. Genomic alterations predictive of response to radiosurgery in recurrent IDH-WT glioblastoma.
    Dono A; Amsbaugh M; Martir M; Smilie RH; Riascos RF; Zhu JJ; Hsu S; Kim DH; Tandon N; Ballester LY; Blanco AI; Esquenazi Y
    J Neurooncol; 2021 Mar; 152(1):153-162. PubMed ID: 33492602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma Knife Stereotactic Radiosurgery in Combination with Bevacizumab for Recurrent Glioblastoma.
    Morris SL; Zhu P; Rao M; Martir M; Zhu JJ; Hsu S; Ballester LY; Day AL; Tandon N; Kim DH; Shepard S; Blanco A; Esquenazi Y
    World Neurosurg; 2019 Jul; 127():e523-e533. PubMed ID: 30954746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
    Dono A; Mitra S; Shah M; Takayasu T; Zhu JJ; Tandon N; Patel CB; Esquenazi Y; Ballester LY
    J Neurooncol; 2021 May; 153(1):153-160. PubMed ID: 33881725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study.
    Bunevicius A; Pikis S; Kondziolka D; Patel DN; Bernstein K; Sulman EP; Lee CC; Yang HC; Delabar V; Mathieu D; Cifarelli CP; Arsanious DE; Dahshan BA; Weir JS; Speckter H; Mota A; Tripathi M; Kumar N; Warnick RE; Peker S; Samanci Y; Barnett G; Hefnawi FE; Al Sideiri G; Sheehan J
    J Neurooncol; 2021 Dec; 155(3):343-351. PubMed ID: 34797526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience.
    Imber BS; Kanungo I; Braunstein S; Barani IJ; Fogh SE; Nakamura JL; Berger MS; Chang EF; Molinaro AM; Cabrera JR; McDermott MW; Sneed PK; Aghi MK
    Neurosurgery; 2017 Jan; 80(1):129-139. PubMed ID: 27428784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I Trial of Radiosurgery Dose Escalation Plus Bevacizumab in Patients With Recurrent/Progressive Glioblastoma.
    Abbassy M; Missios S; Barnett GH; Brewer C; Peereboom DM; Ahluwalia M; Neyman G; Chao ST; Suh JH; Vogelbaum MA
    Neurosurgery; 2018 Sep; 83(3):385-392. PubMed ID: 28973311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.
    Holt DE; Bernard ME; Quan K; Clump DA; Engh JA; Burton SA; Heron DE
    J Cancer Res Ther; 2016; 12(4):1243-1248. PubMed ID: 28169234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.
    Patel M; Siddiqui F; Jin JY; Mikkelsen T; Rosenblum M; Movsas B; Ryu S
    J Neurooncol; 2009 Apr; 92(2):185-91. PubMed ID: 19066727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
    Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
    Umphlett M; Shea S; Tome-Garcia J; Zhang Y; Hormigo A; Fowkes M; Tsankova NM; Yong RL
    BMC Cancer; 2020 Jan; 20(1):47. PubMed ID: 31959133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery for glioblastoma considering tumor genetic profiles: an international multicenter study.
    Bunevicius A; Pikis S; Kondziolka D; Patel DN; Bernstein K; Sulman EP; Lee CC; Yang HC; Delabar V; Mathieu D; Cifarelli CP; Arsanious DE; Dahshan BA; Weir JS; Speckter H; Mota A; Tripathi M; Kumar N; Warnick RE; Sheehan JP
    J Neurosurg; 2022 Jul; 137(1):42-50. PubMed ID: 34740186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impacts of genotypic variants on survival following reoperation for recurrent glioblastoma.
    Dono A; Zhu P; Holmes E; Takayasu T; Zhu JJ; Blanco AI; Hsu S; Bhattacharjee MB; Ballester LY; Kim DH; Esquenazi Y; Tandon N
    J Neurooncol; 2022 Jan; 156(2):353-363. PubMed ID: 34997451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).
    Combs SE; Widmer V; Thilmann C; Hof H; Debus J; Schulz-Ertner D
    Cancer; 2005 Nov; 104(10):2168-73. PubMed ID: 16220556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors predictive of improved overall survival following stereotactic radiosurgery for recurrent glioblastoma.
    Bir SC; Connor DE; Ambekar S; Wilden JA; Nanda A
    Neurosurg Rev; 2015 Oct; 38(4):705-13. PubMed ID: 25864406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab and gamma knife radiosurgery for first-recurrence glioblastoma.
    Zhang JF; Okai B; Iovoli A; Goulenko V; Attwood K; Lim J; Hess RM; Abad AP; Prasad D; Fenstermaker RA
    J Neurooncol; 2024 Jan; 166(1):89-98. PubMed ID: 38175460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.